Китруда, Кецтруда pembrolizumab 100 mg one Bottle MSD, Великобритания Melanoma \r\n The drug Keytruda® is indicated for the treatment of patients with unresectable or metastatic melanoma. \r\n Keytruda® is indicated for adjuvant therapy of melanoma patients with lymph node(s) infection after resection. \r\n Non-clinical cancer of the leg
Keytruda / Kytruda (pembrolizumab) 100 mg, MSD, Ireland
Article:
In Stock
Melanoma
The drug Keytruda® is indicated for the treatment of patients with unresectable or metastatic melanoma.
Keytruda® is indicated for adjuvant therapy of melanoma patients with lymph node(s) infection after resection.
Non-clinical cancer of the leg
- Commercial name:Китруда, Кецтруда
- Сhemical name:pembrolizumab
- Dosage:100 mg
- Quantity:one
- Release form:Bottle
- Виробник:MSD, Великобритания
No reviews yet